FUNDAMENTALS · Fundamentals · HK Healthcare

Beijing Health (Holdings) (2389) Fundamentals 2026 — Revenue Analysis | SniperIQ

Beijing Health (Holdings) (2389) is a HK-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of HK$460M, trading at HK$0.08 on the HKSE. This SniperIQ fundamentals page covers Beijing Health (Holdings)'s valuation, profitability (net margin -64.2%), revenue (HK

57M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapHK$460M
Net Margin-64.2%
Revenue (FY25)HK
57M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Beijing Health (Holdings)'s market cap?

Beijing Health (Holdings) (2389) has a market capitalization of approximately HK$460M, trading at HK$0.08 on the HKSE. Market cap moves with the live share price.

What is Beijing Health (Holdings)'s P/E ratio?

Beijing Health (Holdings)'s trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Beijing Health (Holdings)?

Beijing Health (Holdings) runs a net profit margin of -64.2%, a gross margin of 27.0%, and an operating margin of -34.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Beijing Health (Holdings) generate?

Beijing Health (Holdings) reported revenue of HK

57M for fiscal year 2025, with net income of -HK
01M and earnings per share (EPS) of -0.0167. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Beijing Health (Holdings) pay a dividend?

Beijing Health (Holdings) does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Beijing Health (Holdings) financially healthy?

Beijing Health (Holdings) carries a debt-to-equity ratio of 0.07x and a current ratio of 1.26x, with a market beta of -0.16. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Beijing Health (Holdings) a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Beijing Health (Holdings) (2389) the key facts are: market cap HK$460M, revenue HK

57M, 52-week range 0.056-0.11. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Beijing Health (Holdings)'s full fundamentals live

Get Beijing Health (Holdings)'s 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.